CoChat

From Traditional Ethnopharmacology to Modern Natural Drug Discovery: A Methodology Discussion and Specific Examples

Open access
Pirintsos, Stergios, Panagiotopoulos, Athanasios, Bariotakis, Michalis, Daskalakis, Vangelis, Lionis, Christos, Sourvinos, George, Karakasiliotis, Ioannis, Kampa, Marilena, Castanas, Elias · 2022 · Molecules
Cited by 167

The DOI matches its Crossref record; 13 of the 13 references it cites were found in a registry or an index.

Abstract

Ethnopharmacology, through the description of the beneficial effects of plants, has provided an early framework for the therapeutic use of natural compounds. Natural products, either in their native form or after crude extraction of their active ingredients, have long been used by different populations and explored as invaluable sources for drug design. The transition from traditional ethnopharmacology to drug discovery has followed a straightforward path, assisted by the evolution of isolation and characterization methods, the increase in computational power, and the development of specific chemoinformatic methods. The deriving extensive exploitation of the natural product chemical space has led to the discovery of novel compounds with pharmaceutical properties, although this was not followed by an analogous increase in novel drugs. In this work, we discuss the evolution of ideas and methods, from traditional ethnopharmacology to in silico drug discovery, applied to natural products. We point out that, in the past, the starting point was the plant itself, identified by sustained ethnopharmacological research, with the active compound deriving after extensive analysis and testing. In contrast, in recent years, the active substance has been pinpointed by computational methods (in silico docking and molecular dynamics, network pharmacology), followed by the identification of the plant(s) containing the active ingredient, identified by existing or putative ethnopharmacological information. We further stress the potential pitfalls of recent in silico methods and discuss the absolute need for in vitro and in vivo validation as an absolute requirement. Finally, we present our contribution to natural products’ drug discovery by discussing specific examples, applying the whole continuum of this rapidly evolving field. In detail, we report the isolation of novel antiviral compounds, based on natural products active against influenza and SARS-CoV-2 and novel substances active on a specific GPCR, OXER1.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/molecules27134060

Cites

13 of 13 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 122

  1. Halberstein, 2005, Medicinal plants: Historical and cross-cultural usage patterns, Ann. Epidemiol., 15, 686, 10.1016/j.annepidem.2005.02.004 · DOI · Paper page
  2. Hardy, 2021, Paleomedicine and the Evolutionary Context of Medicinal Plant Use, Rev. Bras. Farmacogn., 31, 1, 10.1007/s43450-020-00107-4 · DOI
  3. Malik, 2011, Production of the anticancer drug taxol in Taxus baccata suspension cultures: A review, Broc. Biochem., 46, 23
  4. Gallego-Jara, J., Lozano-Terol, G., Sola-Martinez, R.A., Canovas-Diaz, M., and de Diego Puente, T. (2020). A Compressive Review about Taxol((R)): History and Future Challenges. Molecules, 25. · DOI · Paper page
  5. Rose, 1992, Taxol: A review of its preclinical in vivo antitumor activity, Anticancer Drugs, 3, 311, 10.1097/00001813-199208000-00001 · doi:10.1097/00001813-199208000-00001
  6. Brade, 1981, Critical Review of Pharmacology, Toxicology, Pharmacokinetics of Vincristine, Vindesine, Vinblastine, International Vinca Alkaloid Symposium—Vindesine, Volume 6, 95, 10.1159/000428623 · doi:10.1159/000428623
  7. Nelson, 1982, The comparative clinical pharmacology and pharmacokinetics of vindesine, vincristine, and vinblastine in human patients with cancer, Med. Pediatr. Oncol., 10, 115, 10.1002/mpo.2950100202 · DOI
  8. Achan, 2011, Quinine, an old anti-malarial drug in a modern world: Role in the treatment of malaria, Malar J., 10, 144, 10.1186/1475-2875-10-144 · DOI · Paper page
  9. Liles, 2016, Diversity and severity of adverse reactions to quinine: A systematic review, Am. J. Hematol., 91, 461, 10.1002/ajh.24314 · DOI
  10. Dai, 2017, The pharmacological activities and mechanisms of artemisinin and its derivatives: A systematic review, Med. Chem. Res., 26, 867, 10.1007/s00044-016-1778-5 · DOI
  11. Fabricant, 2001, The value of plants used in traditional medicine for drug discovery, Environ. Health Perspect., 109, 69
  12. Dias, 2012, A historical overview of natural products in drug discovery, Metabolites, 2, 303, 10.3390/metabo2020303 · DOI · Paper page
  13. Najmi, A., Javed, S.A., Al Bratty, M., and Alhazmi, H.A. (2022). Modern Approaches in the Discovery and Development of Plant-Based Natural Products and Their Analogues as Potential Therapeutic Agents. Molecules, 27. · DOI · Paper page
  14. Fattore, M., and Bruggemann, R. (2017). Analyzing Ethnopharmacological Data Matrices on Traditional Uses of Medicinal Plants with the Contribution of Partial Order Techniques. Partial Order Concepts in Applied Sciences, Springer. · doi:10.1007/978-3-319-45421-4
  15. Karali, 2016, T cell regulation by Phlomis lanata protein extracts in mice, Pharm. Biol., 54, 207, 10.3109/13880209.2015.1027780 · doi:10.3109/13880209.2015.1027780
  16. Murugan, N.A., Podobas, A., Gadioli, D., Vitali, E., Palermo, G., and Markidis, S. (2022). A Review on Parallel Virtual Screening Softwares for High-Performance Computers. Pharmaceuticals, 15. · DOI
  17. Zaman, 2021, Predicting potential medicinal plants with phylogenetic topology: Inspiration from the research of traditional Chinese medicine, J. Ethnopharmacol., 281, 114515, 10.1016/j.jep.2021.114515 · DOI
  18. Zaman, 2022, Phylogenetic exploration of traditional chinese medicinal plants: A case study of Lamiaceae, Pak. J. Bot., 54, 1033, 10.30848/PJB2022-3(19) · doi:10.30848/pjb2022-3(19
  19. Martin, 1995, Accomplishments and challenges in integrating software for computer-aided ligand design in drug discovery, Persp. Drug Discov. Des., 3, 139, 10.1007/BF02174471 · DOI
  20. Boezio, 2017, Network-based Approaches in Pharmacology, Mol. Inform., 36, 1700048, 10.1002/minf.201700048 · DOI · Paper page
  21. Soejarto, 2005, Ethnobotany/ethnopharmacology and mass bioprospecting: Issues on intellectual property and benefit-sharing, J. Ethnopharmacol., 100, 15, 10.1016/j.jep.2005.05.031 · DOI
  22. Mukherjee, 2010, Ethnopharmacology and integrative medicine—Let the history tell the future, J. Ayurveda Integr. Med., 1, 100, 10.4103/0975-9476.65077 · DOI
  23. Heinrich, 2001, Ethnopharmacology in drug discovery: An analysis of its role and potential contribution, J. Pharm. Pharmacol., 53, 425, 10.1211/0022357011775712 · DOI · Paper page
  24. 2015, Ethnobotanical survey of medicinal plants in Bozyazi district of Mersin, Turkey, J. Ethnopharmacol., 173, 105, 10.1016/j.jep.2015.07.009 · DOI
  25. Zhao, 2021, Prevention and treatment of COVID-19 using Traditional Chinese Medicine: A review, Phytomedicine, 85, 153308, 10.1016/j.phymed.2020.153308 · DOI · Paper page
  26. Heinrich, M., and Jäger, A. (2015). Medicinal Plant Research: A Reflection on Translational Tasks. Ethnopharmacology, Karger. · DOI
  27. Thomford, N.E., Senthebane, D.A., Rowe, A., Munro, D., Seele, P., Maroyi, A., and Dzobo, K. (2018). Natural Products for Drug Discovery in the 21st Century: Innovations for Novel Drug Discovery. Int. J. Mol. Sci., 19. · DOI · Paper page
  28. Pirintsos, 2020, The Therapeutic Potential of the Essential Oil of Thymbra capitata (L.) Cav., Origanum dictamnus L. and Salvia fruticosa Mill. and a Case of Plant-Based Pharmaceutical Development, Front. Pharmacol., 11, 522213, 10.3389/fphar.2020.522213 · DOI
  29. Hanlidou, 2004, The herbal market of Thessaloniki (N Greece) and its relation to the ethnobotanical tradition, J. Ethnopharmacol., 91, 281, 10.1016/j.jep.2004.01.007 · doi:10.1016/j.jep.2004.01.007
  30. 2010, The relevance of traditional knowledge systems for ethnopharmacological research: Theoretical and methodological contributions, J. Ethnobiol. Ethnomed., 6, 32, 10.1186/1746-4269-6-32 · DOI
  31. Heinrich, 2010, Ethnopharmacology in the 21st century—Grand challenges, Front. Pharmacol., 1, 8, 10.3389/fphar.2010.00008 · DOI
  32. Laina, 2017, Partial ordering of undesirable effects reported for traditionally used medicinal herbal substances, Toxicol. Environ. Chem., 99, 1230
  33. Brüggemann, R., and Patil, G. (2011). Ranking and Prioritization for Multi-Indicator Systems: Introduction to Partial Order Applications, Springer. · doi:10.1007/978-1-4419-8477-7
  34. Bariotakis, 2019, From wild harvest towards precision agriculture: Use of Ecological Niche Modelling to direct potential cultivation of wild medicinal plants in Crete, Sci. Total Environ., 694, 133681, 10.1016/j.scitotenv.2019.133681 · DOI
  35. Yeung, 2020, The ethnopharmacological literature: An analysis of the scientific landscape, J. Ethnopharmacol., 250, 112414, 10.1016/j.jep.2019.112414 · DOI
  36. Alzweiri, 2011, Ethnopharmacological survey of medicinal herbs in Jordan, the Northern Badia region, J. Ethnopharmacol., 137, 27, 10.1016/j.jep.2011.02.007 · DOI · Paper page
  37. Karousou, 2011, The herbal market of Cyprus: Traditional links and cultural exchanges, J. Ethnopharmacol., 133, 191, 10.1016/j.jep.2010.09.034 · doi:10.1016/j.jep.2010.09.034
  38. 2009, Ethnopharmacological survey of wild medicinal plants in Showbak, Jordan, J. Ethnopharmacol., 123, 45, 10.1016/j.jep.2009.02.031 · DOI · Paper page
  39. Hudaib, 2008, Ethnopharmacological survey of medicinal plants in Jordan, Mujib Nature Reserve and surrounding area, J. Ethnopharmacol., 120, 63, 10.1016/j.jep.2008.07.031 · doi:10.1016/j.jep.2008.07.031
  40. Lardos, 2006, The botanical materia medica of the Iatrosophikon—A collection of prescriptions from a monastery in Cyprus, J. Ethnopharmacol., 104, 387, 10.1016/j.jep.2005.12.035 · doi:10.1016/j.jep.2005.12.035
  41. Said, 2002, Ethnopharmacological survey of medicinal herbs in Israel, the Golan Heights and the West Bank region, J. Ethnopharmacol., 83, 251, 10.1016/S0378-8741(02)00253-2 · DOI · Paper page
  42. Lev, 2000, Ethnopharmacological survey of traditional drugs sold in Israel at the end of the 20th century, J. Ethnopharmacol., 72, 191, 10.1016/S0378-8741(00)00230-0 · doi:10.1016/s0378-8741(00)00230-0
  43. Yaghmour, 1998, Antimicrobial activity of 20 plants used in folkloric medicine in the Palestinian area, J. Ethnopharmacol., 60, 265, 10.1016/S0378-8741(97)00153-0 · DOI · Paper page
  44. Suarez, 1997, Medicinal plants used in the Barros Area, Badajoz Province (Spain), J. Ethnopharmacol., 55, 81, 10.1016/S0378-8741(96)01491-2 · doi:10.1016/s0378-8741(96)01491-2
  45. Honda, 1996, Traditional medicine in Turkey VI. Folk medicine in West Anatolia: Afyon, Kütahya, Denizli, Muğla, Aydin provinces, J. Ethnopharmacol., 53, 75
  46. 1995, A Survey of Plants Used in Jordanian Traditional Medicine, Int. J. Pharmacogn., 33, 317, 10.3109/13880209509065385 · DOI · Paper page
  47. Dafni, 1984, Ethnobotanical survey of medicinal plants in northern Israel, J. Ethnopharmacol., 10, 295, 10.1016/0378-8741(84)90017-5 · doi:10.1016/0378-8741(84)90017-5
  48. Qnais, 2007, Antidiarrheal Activity of the Aqueous Extract of Punica granatum. (Pomegranate) Peels, Pharm. Biol., 45, 715, 10.1080/13880200701575304 · DOI
  49. Mroueh, 2011, Pharmacological evaluation of aqueous extract of Althaea officinalis flower grown in Lebanon, Pharm. Biol., 49, 327, 10.3109/13880209.2010.516754 · doi:10.3109/13880209.2010.516754
  50. Hsu, 2007, Antioxidant activity of extract from Polygonum cuspidatum, Biol. Res.Res., 40, 13
  51. Hsu, 2006, Antioxidant activity of extract from Polygonum aviculare L., Biol. Res., 39, 281, 10.4067/S0716-97602006000200010 · DOI
  52. Perianayagam, 2006, Anti-inflammatory activity of Trichodesma indicum root extract in experimental animals, J. Ethnopharmacol., 104, 410, 10.1016/j.jep.2005.08.077 · doi:10.1016/j.jep.2005.08.077
  53. Garrido, 2004, In vivo and in vitro anti-inflammatory activity of Mangifera indica L. extract (VIMANG), Pharmacol. Res., 50, 143, 10.1016/j.phrs.2003.12.003 · DOI · Paper page
  54. Rajeshkumar, 2002, Antitumour and anticarcinogenic activity of Phyllanthus amarus extract, J. Ethnopharmacol., 81, 17, 10.1016/S0378-8741(01)00419-6 · DOI · Paper page
  55. Olajide, 2000, Studies on the anti-inflammatory and related pharmacological properties of the aqueous extract of Bridelia ferruginea stem bark, J. Ethnopharmacol., 71, 153, 10.1016/S0378-8741(99)00201-9 · DOI
  56. Bhakta, 1998, Studies on Antitussive Activity of Cassia fistula (Leguminosae) Leaf Extract, Pharm. Biol., 36, 140, 10.1076/phbi.36.2.140.4598 · doi:10.1076/phbi.36.2.140.4598
  57. Bartoszewski, 2019, Comprehensive review of antimicrobial activities of plant flavonoids, Phytochem. Rev., 18, 241, 10.1007/s11101-018-9591-z · DOI · Paper page
  58. Adamski, Z., Blythe, L.L., Milella, L., and Bufo, S.A. (2020). Biological Activities of Alkaloids: From Toxicology to Pharmacology. Toxins, 12. · doi:10.3390/toxins12040210
  59. Pizzi, 2021, Tannins medical / pharmacological and related applications: A critical review, Sust. Chem. Pharm., 22, 100481
  60. Metwaly, A.M., Lianlian, Z., Luqi, H., and Deqiang, D. (2019). Black Ginseng and Its Saponins: Preparation, Phytochemistry and Pharmacological Effects. Molecules, 24. · DOI
  61. Yang, 2020, Advances in Pharmacological Activities of Terpenoids, Nat. Prod. Commun., 15, 1934578X20903555
  62. Hinkson, 2020, Accelerating Therapeutics for Opportunities in Medicine: A Paradigm Shift in Drug Discovery, Front. Pharmacol., 11, 770, 10.3389/fphar.2020.00770 · DOI · Paper page
  63. Lionis, 1998, Antioxidant effects of herbs in Crete, Lancet, 352, 1987, 10.1016/S0140-6736(05)61333-5 · doi:10.1016/s0140-6736(05)61333-5
  64. Castree, 2003, Bioprospecting: From theory to practice (and back again), Trans. Inst. Brit. Geograph., 28, 35, 10.1111/1475-5661.00076 · DOI
  65. Buenz, 2004, Techniques: Bioprospecting historical herbal texts by hunting for new leads in old tomes, Trends Pharmacol. Sci., 25, 494, 10.1016/j.tips.2004.07.003 · DOI
  66. Roersch, 2010, Piper umbellatum L.: A comparative cross-cultural analysis of its medicinal uses and an ethnopharmacological evaluation, J. Ethnopharmacol., 131, 522, 10.1016/j.jep.2010.07.045 · DOI
  67. Hao, 2020, Pharmaceutical resource discovery from traditional medicinal plants: Pharmacophylogeny and pharmacophylogenomics, Chin. Herb. Med., 12, 104
  68. Zhu, 2011, Clustered patterns of species origins of nature-derived drugs and clues for future bioprospecting, Proc. Natl. Acad. Sci. USA, 108, 12943, 10.1073/pnas.1107336108 · DOI · Paper page
  69. Williamson, 2011, Cross-cultural comparison of three medicinal floras and implications for bioprospecting strategies, J. Ethnopharmacol., 135, 476, 10.1016/j.jep.2011.03.044 · DOI
  70. Savolainen, 2012, Phylogenies reveal predictive power of traditional medicine in bioprospecting, Proc. Natl. Acad. Sci. USA, 109, 15835, 10.1073/pnas.1202242109 · DOI · Paper page
  71. Kalyvianaki, 2020, Toxicity evaluation of an essential oil mixture from the Cretan herbs thyme, Greek sage and Cretan dittany, NPJ Sci. Food, 4, 20, 10.1038/s41538-020-00080-1 · DOI
  72. Tseliou, 2019, Antiviral effect of an essential oil combination derived from three aromatic plants (Coridothymus capitatus (L.) Rchb. f., Origanum dictamnus L. and Salvia fruticosa Mill.) against viruses causing infections of the upper respiratory tract, J. Herb. Med., 17–18, 100288, 10.1016/j.hermed.2019.100288 · doi:10.1016/j.hermed.2019.100288
  73. Duijker, 2015, Reporting effectiveness of an extract of three traditional Cretan herbs on upper respiratory tract infection: Results from a double-blind randomized controlled trial, J. Ethnopharmacol., 163, 157, 10.1016/j.jep.2015.01.030 · DOI
  74. Anastasaki, M., Bertsias, A., Pirintsos, S.A., Castanas, E., and Lionis, C. (2017). Post-market outcome of an extract of traditional Cretan herbs on upper respiratory tract infections: A pragmatic, prospective observational study. BMC Complement. Altern. Med., 17. · doi:10.1186/s12906-017-1978-7
  75. Panagiotopoulos, 2021, p-cymene impairs SARS-CoV-2 and Influenza A (H1N1) viral replication: In silico predicted interaction with SARS-CoV-2 nucleocapsid protein and H1N1 nucleoprotein, Pharmacol. Res.Res. Perspect, 9, e00798, 10.1002/prp2.798 · DOI
  76. Munos, 2009, Lessons from 60 years of pharmaceutical innovation, Nat. Rev. Drug Discov., 8, 959, 10.1038/nrd2961 · DOI · Paper page
  77. Firn, 2001, Bioprospecting—Why is it so unrewarding?, Biodiv. Conserv., 12, 207, 10.1023/A:1021928209813 · doi:10.1023/a:1021928209813
  78. Zhang, 2017, Computational Multitarget Drug Design, J. Chem. Inf. Model., 57, 403, 10.1021/acs.jcim.6b00491 · DOI · Paper page
  79. Prachayasittikul, 2015, Computer-Aided Drug Design of Bioactive Natural Products, Curr. Top. Med. Chem., 15, 1780, 10.2174/1568026615666150506151101 · doi:10.2174/1568026615666150506151101
  80. Callaway, 2022, What’s next for AlphaFold and the AI protein-folding revolution, Nature, 604, 234, 10.1038/d41586-022-00997-5 · DOI · Paper page
  81. Yuriev, 2015, Improvements, trends, and new ideas in molecular docking: 2012–2013 in review, J. Mol. Recognit., 28, 581, 10.1002/jmr.2471 · DOI · Paper page
  82. Husic, 2018, Markov State Models: From an Art to a Science, J. Am. Chem. Soc., 140, 2386, 10.1021/jacs.7b12191 · DOI · Paper page
  83. Kuzmanic, 2017, Changes in the free-energy landscape of p38 alpha MAP kinase through its canonical activation and binding events as studied by enhanced molecular dynamics simulations, eLife, 6, e22175, 10.7554/eLife.22175 · DOI
  84. Daskalakis, 2020, The conformational phase space of the photoprotective switch in the major light harvesting complex II, Chem. Commun., 56, 11215, 10.1039/D0CC04486E · DOI
  85. Panagiotopoulos, A.A., Karakasiliotis, I., Kotzampasi, D.M., Dimitriou, M., Sourvinos, G., Kampa, M., Pirintsos, S., Castanas, E., and Daskalakis, V. (2021). Natural Polyphenols Inhibit the Dimerization of the SARS-CoV-2 Main Protease: The Case of Fortunellin and Its Structural Analogs. Molecules, 26. · DOI
  86. Panagiotopoulos, 2020, A simple open source bioinformatic methodology for initial exploration of GPCR ligands’ agonistic/antagonistic properties, Pharmacol. Res.Res. Perspect, 8, e00600, 10.1002/prp2.600 · DOI
  87. Sonnhammer, 2020, Pathway-specific model estimation for improved pathway annotation by network crosstalk, Sci. Rep., 10, 13585, 10.1038/s41598-020-70239-z · DOI
  88. Lai, 2020, Editorial: Network Pharmacology and Traditional Medicine, Front. Pharmacol., 11, 1194, 10.3389/fphar.2020.01194 · doi:10.3389/fphar.2020.01194
  89. Wu, 2018, Network-Based Methods for Prediction of Drug-Target Interactions, Front. Pharmacol., 9, 1134, 10.3389/fphar.2018.01134 · DOI · Paper page
  90. Muhammad, 2018, Network Pharmacology: Exploring the Resources and Methodologies, Curr. Top. Med. Chem., 18, 949, 10.2174/1568026618666180330141351 · DOI
  91. Liu, 2020, Computational network biology: Data, models, and applications, Phys. Rep., 846, 1, 10.1016/j.physrep.2019.12.004 · DOI · Paper page
  92. Kibble, 2015, Network pharmacology applications to map the unexplored target space and therapeutic potential of natural products, Nat. Prod. Rep., 32, 1249, 10.1039/C5NP00005J · DOI · Paper page
  93. Hopkins, 2008, Network pharmacology: The next paradigm in drug discovery, Nat. Chem. Biol., 4, 682, 10.1038/nchembio.118 · DOI · Paper page
  94. Guala, 2022, Benefits and Challenges of Pre-clustered Network-Based Pathway Analysis, Front. Genet., 13, 855766, 10.3389/fgene.2022.855766 · DOI
  95. Gramatica, 2012, QSAR Modeling is not “Push a Button and Find a Correlation”: A Case Study of Toxicity of (Benzo-)triazoles on Algae, Mol. Inform., 31, 817, 10.1002/minf.201200075 · DOI · Paper page
  96. Gramatica, 2020, Principles of QSAR Modeling: Comments and Suggestions from Personal Experience, Int. J. Quant. Struct.-Prop. Relatsh., 5, 61
  97. Gramatica, 2007, Principles of QSAR models validation: Internal and external, QSAR Comb. Sci., 26, 694, 10.1002/qsar.200610151 · DOI · Paper page
  98. Schyman, 2017, vNN Web Server for ADMET Predictions, Front. Pharmacol., 8, 889, 10.3389/fphar.2017.00889 · DOI · Paper page
  99. Xiong, 2021, ADMETlab 2.0: An integrated online platform for accurate and comprehensive predictions of ADMET properties, Nucleic Acids Res., 49, W5, 10.1093/nar/gkab255 · DOI · Paper page
  100. Wei, 2022, Interpretable-ADMET: A web service for ADMET prediction and optimization based on deep neural representation, Bioinformatics, 38, 2863, 10.1093/bioinformatics/btac192 · DOI
  101. Gupta, 2018, Docking techniques in pharmacology: How much promising?, Comput. Biol. Chem., 76, 210, 10.1016/j.compbiolchem.2018.06.005 · DOI · Paper page
  102. Murugan, 2022, Artificial intelligence in virtual screening: Models versus experiments, Drug Discov. Today, 27, 1913, 10.1016/j.drudis.2022.05.013 · DOI
  103. Brown, 2021, A Decade of FDA-Approved Drugs (2010–2019): Trends and Future Directions, J. Med. Chem., 64, 2312, 10.1021/acs.jmedchem.0c01516 · DOI · Paper page
  104. Ripphausen, 2010, Quo vadis, virtual screening? A comprehensive survey of prospective applications, J. Med. Chem., 53, 8461, 10.1021/jm101020z · DOI · Paper page
  105. Kunimoto, 2022, From traditional to data-driven medicinal chemistry: A case study, Drug Discov. Today, 27, 2065, 10.1016/j.drudis.2022.04.017 · DOI
  106. Wang, 2021, TCM network pharmacology: A new trend towards combining computational, experimental and clinical approaches, Chin. J. Nat. Med., 19, 1
  107. Singh, 2021, Treasuring the computational approach in medicinal plant research, Prog. Biophys. Mol. Biol., 164, 19, 10.1016/j.pbiomolbio.2021.05.004 · DOI
  108. Sabe, 2021, Current trends in computer aided drug design and a highlight of drugs discovered via computational techniques: A review, Eur. J. Med. Chem., 224, 113705, 10.1016/j.ejmech.2021.113705 · DOI · Paper page
  109. Cui, 2013, Chapter Twenty-Five—Case History: Xalkori™ (Crizotinib), a Potent and Selective Dual Inhibitor of Mesenchymal Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) for Cancer Treatment, Ann. Rep. Med. Chem., 48, 421
  110. Cui, 2020, Discovering Anti-Cancer Drugs via Computational Methods, Front. Pharmacol., 11, 733, 10.3389/fphar.2020.00733 · DOI · Paper page
  111. Li, R., and Stafford, J. (2009). Structure-Based Design and Characterization of Axitinib. Kinase Inhibitor Drugs, John Wiley & Sons, Inc. · DOI
  112. Gervasio, F., Spiwok, V., and Mannhold, R. (2019). Biomolecular Simulations in Structure-Based Drug Discovery, Willey. · DOI
  113. Kampa, 2000, Wine antioxidant polyphenols inhibit the proliferation of human prostate cancer cell lines, Nutr. Cancer, 37, 223, 10.1207/S15327914NC372_16 · DOI · Paper page
  114. Damianaki, 2000, Potent inhibitory action of red wine polyphenols on human breast cancer cells, J. Cell Biochem., 78, 429, 10.1002/1097-4644(20000901)78:3<429::AID-JCB8>3.0.CO;2-M · DOI · Paper page
  115. Nifli, 2005, Monomeric and oligomeric flavanols are agonists of membrane androgen receptors, Exp. Cell Res., 309, 329, 10.1016/j.yexcr.2005.06.011 · DOI
  116. Nifli, 2005, Polyphenol interaction with the T47D human breast cancer cell line, J. Dairy Res., 72, 44, 10.1017/S0022029905001172 · doi:10.1017/s0022029905001172
  117. Kampa, 2011, Novel oligomeric proanthocyanidin derivatives interact with membrane androgen sites and induce regression of hormone-independent prostate cancer, J. Pharmacol. Exp. Ther., 337, 24, 10.1124/jpet.110.177246 · DOI
  118. Kalyvianaki, 2017, Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancer, Sci. Rep., 7, 44418, 10.1038/srep44418 · DOI
  119. Panagiotopoulos, 2022, OXER1 mediates testosterone-induced calcium responses in prostate cancer cells, Mol. Cell Endocrinol., 539, 111487, 10.1016/j.mce.2021.111487 · DOI
  120. Kampa, 2004, The opioid agonist ethylketocyclazocine reverts the rapid, non-genomic effects of membrane testosterone receptors in the human prostate LNCaP cell line, Exp. Cell Res., 294, 434, 10.1016/j.yexcr.2003.11.027 · DOI
  121. Panagiotopoulos, 2021, New Antagonists of the Membrane Androgen Receptor OXER1 from the ZINC Natural Product Database, ACS Omega, 6, 29664, 10.1021/acsomega.1c04027 · DOI
  122. Osakwe, O., and Rizvi, S. (2016). Social Aspects of Drug Discovery, Development and Commercialization, Academic Press.

Cited by

See all 167

Metadata

Authors
Pirintsos, S., Panagiotopoulos, A., Bariotakis, M., Daskalakis, V., Lionis, C., Sourvinos, G., Karakasiliotis, I., Kampa, M., & Castanas, E.
Venue
Molecules
Publisher
MDPI AG
Published
2022-06-24
Volume
27
Issue
13
Pages
4060
ISSN
1420-3049 (ISSN-L)
OpenAlex
W4283585224
Cited by
167
References
13
FWCI
16.34
Type
journal article
Language
en
Open access
gold
Funders
  • Hellenic Foundation for Research and Innovation (H.F.R.I.) (3725, MIS-5000432)
  • Greece and the European Union (European Social Fund (ESF) (3725, MIS-5000432)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.